Guangdong Biolight Meditech News

Research Report Nugge丨Huaxin Securities: Paulite achieved a national layout of blood purification consumables and gave it the first “buy” rating

Gelonghui FinanceJul 31, 2023 15:10

Paulette (300246) 2023 Interim Report Review: Continuously Optimizing Product Structure, Reducing Costs, Increasing Efficiency, and Steady Progress

光大證券Jul 31, 2023 07:47

Paulette (300246) 2022 Annual Report and 2023 Quarterly Report Reviews: Revenue achieved steady growth in '22 and performance in '23 is expected to reach an inflection point

光大證券Apr 20, 2023 00:00

Paulette (300246) 2022 Third Quarter Report Review: The Impact of the Epidemic Disturbance Weakens Product Iteration Enriches Pipelines

光大證券Oct 28, 2022 00:00

Paulette (300246): The time is right to lay out new medical infrastructure for two-wheel drive hemodialysis and monitoring equipment

光大證券May 21, 2022 00:00

Paulette (300246): The impact of raw material costs and exchange rates on current performance growth does not hinder long-term investment value

廣證恆生Apr 25, 2018 00:00

Paulette (300246) Quarterly report comments: the long-term development of the hemodialysis product line is becoming clearer; the decline in sales of monitors is a drag on the results of the third quarter.

東吳證券Oct 24, 2017 00:00

Paulette (300246): 9.64% growth in the third quarter of 2017. Short-term growth slowdown does not hinder the company's long-term high growth trend.

廣證恆生Oct 23, 2017 00:00

Paulette (300246) report comments: thanks to the high growth of hemodialysis business in 17 years, H1 performance achieved a high growth of 30%.

廣證恆生Aug 28, 2017 00:00

Comment on Paulette (300246): the rapid development of hemodialysis product line leads to the sustained and rapid growth of the company's performance.

東吳證券Aug 27, 2017 00:00

Paulette (300246) report comments: hemodialysis business continues to maintain steady growth

山西證券Aug 25, 2017 00:00

Comments on Paulette (300246): monitoring plate under pressure to watch the development of hemodialysis

中金公司Aug 25, 2017 00:00

Paulette (300246) in-depth report: seeds with large space and small market capitalization in the implementation of the whole industry chain of hemodialysis

廣證恆生Aug 21, 2017 00:00

Comments on the pre-increase of Paulette (300246): the layout of the whole industry chain of hemodialysis continues to improve and the business continues to grow at a high rate.

聯訊證券Aug 2, 2017 00:00

宝莱特(300246)：血透业务稳步推进 中期业绩预增20%-45%

廣證恆生Jul 17, 2017 00:00

宝莱特(300246)：收购华中地区血透耗材厂商柯瑞迪 打破业务地域限制

廣證恆生Jul 6, 2017 00:00

宝莱特(300246)：持续完善血透全产链布局 血透耗材生产基全国布局基本完成

東吳證券Jul 4, 2017 00:00

宝莱特(300246)：收购柯瑞迪深入华中地区 透析粉液全国布局初具雏形

華金證券Jul 4, 2017 00:00

宝莱特(300246)：春江水暖鸭先知 董事长“保底”倡议员工增持

聯訊證券Jun 7, 2017 00:00

宝莱特(300246)：董事长坚定看好公司长期发展 倡议员工“保底”增持 彰显雄心与信心

東吳證券Jun 4, 2017 00:00